| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/01/2009 | CN100507548C Acousto-mechanical detection systems and methods of use |
| 07/01/2009 | CN100506793C Vitamin D* lactam derivative |
| 07/01/2009 | CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 06/30/2009 | US7553977 For the production of solar cells and molecular memory devices; halogenating a 5-phosphono, 1-acyldipyrromethane to produce a 9-halo, 5-phosphono, 1-acyldipyrromethane |
| 06/30/2009 | US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 06/30/2009 | US7553864 TACE inhibitors; rheumatoid arthritis, osteoarthritis, periodontitis, gingivitis, corneal ulceration, neovascular glaucoma, inflammatory bowel disease, multiple sclerosis and psoriasis |
| 06/30/2009 | US7553861 Type-2 diabetes |
| 06/30/2009 | US7553836 7-(4-Chlorophenyl)-2-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one trifluoroacetic acid salt; obesity; antidiabetic agents; antidepressants; anxiolytic agents; combination with antipsychotic drugs enhanced therayp for schizophrenic disorders |
| 06/30/2009 | CA2356154C Ligands and complexes for enantioselective hydrogenation |
| 06/25/2009 | WO2009079593A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 06/25/2009 | WO2009079392A1 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 06/25/2009 | WO2009078878A1 Compounds having a diphenyl oxide backbone and maleimide functional group |
| 06/25/2009 | WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 06/25/2009 | US20090163722 N-tert-butoxycarbonyl-2-pyrrolidinones and production method thereof |
| 06/25/2009 | US20090163719 Catalyst compositions and their use in the de-enrichment of enantiomerically enriched substrates |
| 06/25/2009 | US20090163718 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES |
| 06/25/2009 | US20090163715 Intermediate in Production of [2-(3,3,5,5-Tetramethylcyclohexyl)phenyl]Piperazine Compound |
| 06/25/2009 | US20090163705 Cationic lipids |
| 06/25/2009 | US20090163555 Isolated optically active stereoisomers are useful for enhancing an immuneresponse, for treating autoimmune diseases and asantitumor agents, bacteriacides, fungicides or viricides; one pot synthesis of1-(3-a3S,5R-1-(3-amino-5-carboxy-2-oxopyrrolidin-3-ylmethyl)pyridinium bromide hydrobromide |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090163462 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 06/25/2009 | US20090162420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids |
| 06/24/2009 | EP2072496A1 Method for producing high-purity quaternary ammonium salt |
| 06/24/2009 | EP1957450B1 Serotonin transporter (sert) inhibitors |
| 06/24/2009 | EP1926709A4 Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity |
| 06/24/2009 | EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 06/24/2009 | CN101466671A Novel microbiocides |
| 06/24/2009 | CN101466670A Benzamide derivatives as inhibitors of histone deacetylase |
| 06/24/2009 | CN101466669A Phenyl pyrrole aminoguanidine derivatives |
| 06/24/2009 | CN101466668A Pyrrolidine compounds as renin inhibitors |
| 06/24/2009 | CN101462998A Process for synthesizing effective azolylamine derivative |
| 06/24/2009 | CN101462997A Preparation of N-phenyl maleimide |
| 06/24/2009 | CN101462996A Preparation of 4-cyclohexyl proline derivative |
| 06/24/2009 | CN100505377C Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 06/24/2009 | CN100503600C Pesticidal heterocycles |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503565C Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 06/24/2009 | CN100503564C Process for preparing high purity crystal atorvastatin sodium |
| 06/24/2009 | CN100503563C Arylpyrrole N-oxalate derivatives, and their preparation and use as pesticide |
| 06/24/2009 | CN100503562C Pyrrolidone derivatives as MAOB inhibitors |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/23/2009 | US7550604 Pyrrole compounds with antibacterial activity against staphylococcus, bacillus, escherichia, candida; use in treatment of melanoma and colorectal adenocarcinoma |
| 06/23/2009 | US7550502 e.g. 5-[(R)-1-(4-tert-Butyl-phenyl)-5-oxo-pyrrolidin-2-ylmethoxy]-pentanoic acid; prostaglandin EP2 agonist; ocular hypotensive, antiinflammatory agent; glaucoma, inflammatory bowel disease and as presurgical adjuncts |
| 06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550487 Factor Xa inhibitors; anticoagulants; thrombotic disorders; (3R,4R)-3-(4-Chloro-phenylcarbamoyl)-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid propyl ester for example |
| 06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
| 06/23/2009 | US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/23/2009 | US7550453 Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide |
| 06/23/2009 | US7550448 Therapeutic compounds |
| 06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/18/2009 | WO2009076530A1 Heteroaryl salts and methods for producing and using the same |
| 06/18/2009 | WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 06/18/2009 | WO2009074733A2 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 06/18/2009 | WO2009074534A1 Method for the vinylation of amides |
| 06/18/2009 | WO2009074157A1 Fully-modified phenyl pyrrole aminoguanidines |
| 06/18/2009 | WO2009054693A3 Process for the preparation of atorvastatin |
| 06/18/2009 | WO2009036996A3 Small molecule bradykinin b1 receptor antagonists |
| 06/18/2009 | WO2009015485A8 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090156807 Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone |
| 06/18/2009 | US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 06/18/2009 | US20090156616 Therapeutic agents |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | US20090156485 Method for coupling keratin-binding polypeptides with effector molecules which support carboxylic groups or sulfonic acid groups |
| 06/18/2009 | US20090155862 Process for the preparation of 2-hydroxymethyl-pyrrolidine-3,4-diols |
| 06/18/2009 | CA2708150A1 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | CA2706679A1 Novel compounds 010 |
| 06/17/2009 | EP2070912A1 Method for the vinylation of amides |
| 06/17/2009 | EP2069299A2 Anesthetic compounds |
| 06/17/2009 | EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 06/17/2009 | EP1856102B1 Medicaments for alzheimer |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | EP1383736B1 Peptide deformylase inhibitors |
| 06/17/2009 | CN101460457A Total synthesis of salinosporamide a and analogs thereof |
| 06/17/2009 | CN101460456A Pyrrolidine analogue for preventing neurogenic pain and method for production thereof |
| 06/17/2009 | CN101456837A Synthetic method of zinc pyrrolidone carboxylate |
| 06/17/2009 | CN100500662C Alkyl ether derivatives or salts thereof |
| 06/17/2009 | CN100500653C Method for synthesizing 2-pyrrole methyl formate |
| 06/16/2009 | US7547765 For modifying polypeptides; shikimic acid, quinic acid, or carbohydrate derivatives of polyalkylene glycols; improves bioavailability of modified peptides such as enzyme, a cytokine or a hormone e.g. interferon beta or granulocyte colony stimulating factor; biodrugs |
| 06/16/2009 | US7547722 Chemical compounds |
| 06/16/2009 | CA2447640C Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage |
| 06/16/2009 | CA2414847C Process for the preparation of substituted octanoyl amides |
| 06/16/2009 | CA2339996C Method for treating hot flashes in humans |
| 06/11/2009 | WO2009073592A2 Sulfur containing fluoroalkyl amines and isocyanates |
| 06/11/2009 | WO2009073056A1 Novel tetracycline derivatives as antibacterial agents |
| 06/11/2009 | WO2009072621A1 Substituted dihydroazole compound and pest control agent |
| 06/11/2009 | WO2009072139A1 Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof |
| 06/11/2009 | WO2009071509A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | WO2009071479A1 Method for producing n-vinyl pyrrolidone from lactone-free pyrrolidone |
| 06/11/2009 | WO2009071101A1 N-modified aminoguanidine derivatives |
| 06/11/2009 | WO2009055289A3 Therapeutic substituted lactams |
| 06/11/2009 | WO2009054682A3 Prodrug of atrovastatin by cholesterol's synthesis inhibitors |
| 06/11/2009 | WO2009051718A3 Calcium receptor modulating agents |
| 06/11/2009 | WO2008157467A3 Pyrrolidine-2,5-dione derivatives for use in friction modification |
| 06/11/2009 | WO2008067873A8 Trifluoromethoxyphenyl-substituted tetramic acid derivatives as pesticides and/or herbicides |
| 06/11/2009 | US20090149661 N-Substituted 3,4-Alkylenedioxypyrroles, Ester Substituted Dihydroxypyrroles and Methods for Synthesis of These Pyrroles |
| 06/11/2009 | US20090149528 Cinnamic acid amides |